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To understand the mechanisms underlying mutagenesis in eu-
karyotes better, we have cloned mouse and human homologs of
the Escherichia coli dinB gene. E. coli dinB encodes DNA polymerase
IV and greatly increases spontaneous mutations when overex-
pressed. The mouse and human DinB1 amino acid sequences share
significant identity with E. coli DinB, including distinct motifs
implicated in catalysis, suggesting conservation of the polymerase
function. These proteins are members of a large superfamily of
DNA damage-bypass replication proteins, including the E. coli
proteins UmuC and DinB and the Saccharomyces cerevisiae pro-
teins Rev1 and Rad30. In a phylogenetic tree, the mouse and human
DinB1 proteins specifically group with E. coli DinB, suggesting a
mitochondrial origin for these genes. The human DINB1 gene is
localized to chromosome 5q13 and is widely expressed.
In Escherichia coli, mutagenesis associated with exposure toDNA-damaging agents requires a specialized system (the SOS
system), which processes the damage in an error-prone fashion,
resulting in mutations (1). Recent in vitro studies with purified
reconstituted systems have shown that E. coli UmuC protein, in
conjunction with UmuD9 protein (both of which are encoded by
SOS-regulated genes; ref. 1), single-strand binding protein, and
activated RecA protein, can facilitate error-prone bypass of
DNA lesions by DNA polymerase III holoenzyme (2, 3). The
dinB gene of E. coli (sometimes referred to as dinP; ref. 4) is also
regulated by the SOS system and is required for untargeted
(spontaneous) mutations in phage l when infected cells are
exposed to UV radiation (5). Additionally, overexpression of the
cloned dinB gene in unirradiated E. coli cells carrying plasmids
dramatically increases the mutational burden in the plasmid
DNA (6). Recently, E. coli DinB protein has been purified and
shown to have a specialized DNA polymerase activity (7).
E. coli DinB protein is homologous to an uncharacterized
protein from Caenorhabditis elegans (F22B7.6), the Saccharo-
myces cerevisiae Rev1 protein, and E. coli UmuC protein (4).
Like UmuC protein, Rev1 is involved in DNA damage-induced
mutagenesis in yeast (8). Rev1 protein has been shown to possess
an unusual type of DNA polymerase activity that efficiently
inserts dCMP residues across from sites of base loss in a
templateyprimer-dependent reaction; this enzyme has been
called a deoxycytidyl transferase (9). More recently, the yeast
Rad30 protein, which is also homologous to UmuC and DinB
(10, 11), has been shown to be a DNA polymerase (DNA
polymerase h) that accurately replicates thymine dimers in
template DNA (12). A human homolog of Rad30 has properties
very similar to that of yeast DNA polymerase h (13), and patients
from the variant group of the cancer-prone hereditary disease
xeroderma pigmentosum (XPV) have been shown to carry
mutations in this homolog of RAD30 (14, 15). Collectively, these
observations suggest that members of the UmuCyDinB super-
family are all replication-bypass DNA polymerases. However,
these polymerases may differ in their fidelity andyor affinity for
various types of damaged DNA.
Here, we report the cDNA and translated amino acid
sequence of mouse and human homologs of the E. coli dinB
gene. We have performed phylogenetic analysis of the UmuCy
DinB superfamily and identified four distinct subfamilies. All
members of the UmuCyDinB superfamily share predicted
catalytic domains as well as helix–hairpin–helix (HhH) DNA-
binding domains, consistent with the notion that they are DNA
polymerases. Beyond these regions, the superfamily shows
considerable diversity of domain architecture. In particular,
the human and mouse DinB homologs contain a distinct
version of a Zn-finger module that is found in several other
enzymes implicated in DNA repair. The human gene (DINB1)
maps to chromosome 5q13 and is expressed at low but varying
levels in all tissues tested. Expression of DINB1 mRNA is
highest in testis, and multiple transcripts are present in this
tissue.
Materials and Methods
Cloning and Sequencing of the Mouse Dinb1 and Human DINB1 Genes.
Total RNA from mouse embryonic fibroblasts or mouse testis
was used as a template for first-strand cDNA synthesis by using
the Superscript Preamplification System (Life Technologies,
Rockville, MD) according to the manufacturer’s directions.
Degenerate primers were designed based on conserved se-
quences in the E. coli DinB and C. elegans F22B7.6 proteins. The
degenerate primers capable of encoding C. elegans F22B7.6
amino acids 93–99 [YFAAVEM] and amino acids 289–296
[NKPNGQ(YyF)V] were DPH1C (59-CGA ATT CTA YTT
YGC NGC IGT NGARAT G-39) and DPH4NC (59-CGG GAT
CCA CRW AYT GIC CRT TIG GYT TRT T-39), where Y 5
CyT, N 5 AyCyGyT, I 5 inosine, R 5 AyG, and W 5 AyT.
PCRs were performed by using AmpliTaq polymerase and
conditions recommended by the manufacturer (Perkin–Elmer).
Touchdown PCR was performed with annealing at 60–51°C for
2 cycles and 50°C for 22 cycles. Amplification from mouse cDNA
with these primers resulted in a product of 700 bp. This portion
of the mouse Dinb1 gene was used to generate a random-primed
probe for screening a mouse testis cDNA library and a human
HeLa cell cDNA library. Two partial cDNA clones obtained
from each library were sequenced. Multiple rounds of 59 and 39
rapid amplification of cDNA ends were used to extend the
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putative cDNA sequences of the mouse and human genes by
using rapid amplification of cDNA ends kits according to the
manufacturer’s directions (Life Technologies). In addition, IM-
AGE clones 2063393 [DINB1 expressed sequence tag (EST)
AI375146], 1311317 (Dinb1 EST AA920064), and 385429 (Dinb1
EST W62931) were purchased (Research Genetics, Huntsville,
AL) and sequenced. PCR products were cloned into vectors
pCRII (Invitrogen) or pGEM-T Easy (Promega) by T overhang
ligation.
Databases and Protein Sequence Analysis. The databases used were
the nonredundant database of protein sequences and the data-
base of nucleotide sequences of unfinished bacterial genomes at
the National Center for Biotechnology Information (National
Institutes of Health). The nonredundant database was searched
with the gapped BLAST program and the PSI-BLAST as described
(16, 17). The PSI-BLAST program normally was run to conver-
gence, with the e value of 0.01 as the cutoff for including
sequences in the profile. Multiple alignments were constructed
with the CLUSTALX program (16) and modified manually on the
basis of the alignment generated by PSI-BLAST. For phylogenetic
tree construction, large inserts and ambiguously aligned regions
were removed from the multiple alignment. Phylogenetic trees
were constructed by using the neighbor-joining method (18) with
1,000 bootstrap replications as implemented in the PHYLIP
package (19).
Chromosome Mapping and Fluorescence in Situ Hybridization. PCR
primers designed to produce a human-specific product from the
59 end of the DINB1 gene were used to screen the NIGMS
humanyrodent somatic cell hybrid mapping panel 2. Sequences
of the primers were, for forward, 59-TGGATAGCACAAAG-
GAGAAGTGTG-39 and, for reverse, 59-AATCTGGACCCCT-
TCGTGGCTTCC-39. Screening with the PCR primers above
yielded a single clone designated pDJ487d14. Fluorescence in
situ hybridization was performed as described (20) with biotin-
ylated pDJ487d14 as the probe against normal male donor
metaphase chromosomes from cells labeled with BrdUrd for the
last 4.5 h of culture (21).
Northern Blot Analysis of DINB1 Expression. A human multiple-
tissue Northern blot II (CLONTECH) containing 2 mg of
poly(A)1 RNAylane was hybridized with a labeled random-
primed human DINB1 cDNA probe (nucleotides 659–1,454)
according to the manufacturer’s directions.
Reverse Transcription–PCR (RT-PCR) Analysis of DINB1 Expression.
RT-PCR was performed on cDNAs from multiple human tissues
by using primers complementary to the 59 and 39 ends of the
human ORF. The primers used were hDinB-59 (59-GTG GAT
CCG CCA TGG ATAGCA CAA AGG AGA AGT G-39) and
hDinB-39 (59-CAT ACC CTT GAT ATA TTT TTT AAG TAG
TCG ACC GCG GAT CCA T-39). The amount of cDNA used
per reaction was as follows: 5 ml of 100 ngyml HeLa cell library
cDNA, 2 ml of 2–10 ngyml testis cDNA (Origene, Rockville,
MD), and 5 ml of 0.2 ngyml each cDNA from human multiple
cDNA panel I (CLONTECH). PCRs were performed by using
2.5 units of Expand High Fidelity DNA polymerase according to
the manufacturer’s suggestions (Roche Molecular Biochemi-
cals), and touchdown PCR was performed as described above.
Samples (20 ml) were analyzed on a 1% agarose gel in TBE
buffer (90 mM Trisy64.6 mM boric acidy2.5 mM EDTA, pH 8.3).
Results
cDNA and Protein Sequences of Human and Mouse DinB Homologs.
The human DINB1 sequence of 4,074 nucleotides (GenBank
accession no. AF163570) contains an ORF of 2.6 kilobases (kb)
that can encode a protein of 870 amino acids with a predicted
molecular mass of 99 kDa (Fig. 1). The mouse Dinb1 gene
sequence of 4,263 nucleotides (GenBank accession no.
AF163571) contains an ORF of 2.55 kb that can encode a protein
of 852 amino acids with a predicted molecular mass of 96 kDa
(Fig. 1). The context of the translation initiation codon of the
human DINB1 ORF (ACCAUGG) is a perfect match to the
Kozak consensus sequence (22). That of the mouse Dinb1 ORF
(AUCAUGG) is also a good match, especially in the key 24 and
13 positions. The predicted ORFs of the mouse and human
genes seem to be complete, because stop codons are present in
all three reading frames upstream and downstream of the protein
coding regions. Furthermore, the nucleotide sequence identity
between the mouse and human genes decreases dramatically
immediately outside the putative coding regions, suggesting that
these sequences are within the untranslated regions (UTRs).
The sequenced region of the human 39 UTR contains a
putative AAUAAA polyadenylation signal at nucleotide 3,276,
which is not always used as a transcriptional termination signal,
because additional 39 UTR sequence is present beyond this point
(data not shown). Tissue-specific alternative polyadenylation
that uses this signal might account for additional DINB1 tran-
scripts observed in testis by Northern blotting (see Fig. 5). The
human DINB1 39 UTR also contains six copies of the pen-
tanucleotide AUUUA (data not shown); such AU-rich elements,
called AREs, have been shown to play a role in destabilization
of mRNAs (23). The mouse cDNA is apparently complete,
because its size is consistent with the largest mRNA (4.4 kb)
detected by Northern analysis (data not shown). The 39 UTR of
the mouse Dinb1 gene contains a consensus AAUAAA poly-
adenylation sequence at position 4,201 and has 10 copies of the
AUUUA destabilization signal (data not shown).
Domain Organization and Phylogenetic Analysis of the UmuCyDinB
Superfamily. The predicted human and mouse DinB1 proteins are
substantially hydrophilic (30% acidicybasic residues) and con-
tain bipartite nuclear localization signals at their C termini. The
conserved portion of the UmuCyDinB superfamily, including
the mammalian DinB homologs, consists of the N-terminal
nucleotidyl transferase domain, two tandem HhH domains
implicated in DNA binding, and a C-terminal domain of un-
known function (Figs. 2 and 3). No sequence similarity between
the DinB nucleotidyl transferase domain and other known
nucleotidyl transferasesyDNA polymerases (or any other en-
zymes) was detected. (The PSI-BLAST program was run to con-
vergence with a liberal cutoff of e 5 0.1 for each member of the
superfamily.) However, the multiple alignment of the DinB
homologs reveals the presence of two highly conserved motifs
that center at an invariant DE doublet (motif 2) and an DXD
signature (motif 1) present in most family members (Fig. 2). Both
residues of the invariant DE doublet are essential for the DNA
polymerase activity of yeast DNA polymerase h (12). Conserved
negatively charged residues flanked by hydrophobic residues are
a typical feature of many polymerases (24, 25), in which they
coordinate divalent cations directly involved in catalysis (26, 27).
By inference, a similar role seems likely for the conserved acidic
residues of the UmuCyDinB superfamily.
The mammalian DinB homologs also contain a duplicated
C2HC Zn-cluster domain (Fig. 3). This distinctive version of the
Zn finger is present (in combination with other enzymatic and
binding domains) in two characterized DNA repair proteins,
namely yeast Snm1 (28) and Rad18 (29), the ORC6 subunit of
the yeast origin-recognition complex (30), and several unchar-
acterized proteins (Fig. 3). The apparent orthologs of Snm1 from
higher eukaryotes lack the C2HC Zn cluster (L.A. and E.V.K.,
unpublished observations), underscoring the evolutionary mo-
bility of this domain. Rad18 is a DNA-binding protein with two
identifiable distinct domains, a RING finger and the C2HC Zn
cluster (29, 31). Because RING domains typically are associated






with specific protein–protein interactions (32), it is possible that
the Zn cluster is involved in protein–DNA binding. Hence, the
mammalian homologs of DinB seem to possess two unrelated
DNA-binding domains, the double-HhH domain and the Zn
cluster. A C2H2 Zn finger unrelated to the Zn cluster is present
in the human XPV protein and its fungal homologs (Fig. 3),
although S. cerevisiae Rad30 contains a degenerate version (Fig.
3). This observation underscores the functional association of
the UmuCyDinB superfamily nucleotidyl transferases with Zn-
binding modules that are likely to provide additional contacts
with DNA and shows the plasticity of domain organization of
these proteins, a general feature of DNA repair proteins (33).
The UmuCyDinB superfamily seems to be represented in all
eukaryotes but shows a patchy distribution in bacteria and, thus
far, has been identified in only one archaeon, Sulfolobus sofa-
taricus (34). Among bacteria, this family is represented in all
Gram-positive bacteria and in some Gram-negative Proteobac-
teria, but, as yet, the family has not been found in other lineages.
Phylogenetic analysis of the UmuCyDinB superfamily reveals
several distinct groups that are convincingly supported by the
bootstrap test (Fig. 4). These can be separated into four sub-
families exemplified by E. coli UmuC protein, E. coli DinB
protein, S. cerevisiae Rev1 protein, and S. cerevisiae Rad30
protein. The Rev1 and Rad30 subfamilies are exclusively eu-
Fig. 1. Amino acid alignment of the mouse (Mus musculus; Mm) and human (Homo sapiens; Hs) DinB proteins. The alignment was generated with CLUSTALW.
Identical residues are shaded in dark gray. Similar residues are shaded in light gray. Sites in the mouse DinB1 protein sequence corresponding to the degenerate
primers used for cloning are underlined in white (lines 2 and 6 of the paired sequences). Putative functional units are overlined: NT, nucleotidyl transferase; HhH,
helix–hairpin–helix; Zn cluster, modified Zn cluster; NLS, bipartite nuclear localization signal. The positions of the predicted deletions in the two isoforms of the
mouse [amino acid positions 231–310 () and 509–813 (F)] and human [amino acid positions 420–509 () and 453–831 (E)] DinB1 proteins resulting from
alternative splicing of transcripts in testis are indicated.
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karyotic, whereas the UmuC subfamily comprises only bacterial
proteins (although this finding is not statistically supported as
strongly as in the other families). The mouse and human DinB
homologs belong to a branch that includes the bacterial DinB
protein and its eukaryotic homologs from S. pombe and C.
elegans (Fig. 4), suggesting a mitochondrial origin for these
eukaryotic genes, with subsequent fusion of the Zn-cluster and
the C-terminal globular domains. The presence of N-terminal
extensions in the eukaryotic proteins (Fig. 3) that could serve as
mitochondrial import peptides is consistent with this interpre-
tation. The phylogenetic position of the DinB homolog from
Sulfolobus is uncertain, and in general, it is not possible to
propose a definitive evolutionary scenario for this superfamily.
Given the presence of the umuC-related mucB genes on plasmids
and bacteriophage SPBc2 (35), a major contribution of horizon-
tal gene transfer to the current distribution of the UmuCyDinB
superfamily seems likely.
Chromosomal Mapping of the Human DINB1 Gene. PCR analysis of
the NIGMS humanyrodent somatic-cell hybrid-mapping panel 2
Fig. 2. Conserved motifs within the DinB branch of the UmuCyDinB superfamily. The two conserved motifs containing the putative catalytic residues mentioned
in the text (marked by asterisks) and the two HhH modules are overlined. Gene identification numbers are, for E. coli, 2501652; for Schizosaccharomyces pombe,
4038629; and, for C. elegans, 465873. The consensus that includes residues conserved in all aligned sequences is shown beneath the alignment with the following
designations: a, aromatic (F, Y, and W); h, hydrophobic (A, C, I, L, V, M, F, Y, and W); p, polar (D, E, N, Q, K, R, H, S, and T); c, charged (D, E, K, and R); 1, positively
charged (K and R); 2, negatively charged (D and E); s, small (G, A, S, P, V, D, and N); and u, tiny (G, A, and S). Conserved residues are color coded according to
the consensus.
Fig. 3. Domain architecture of the UmuCyDinB superfamily. N, N-terminal nucleotidyl transferase domain; C, conserved C-terminal domain of unknown
function; HhH, helix–hairpin–helix; C2HC, Zn cluster; C2H2, Zn finger; X1yX2, uncharacterized domains. The RING domain in Rad18 is designated by a yellow
circle. The sequences are grouped by the distinct domain organizations of the respective proteins. Abbreviations: Sc, S. cerevisiae; Sp, S. pombe; Ce, C. elegans;
Hs, H. sapiens; Ec, E. coli; 100 AA, 100 amino acids.






with primers specific for the human DINB1 cDNA yielded
amplification products exclusively in the human control lanes
and in the lane for the human chromosome 5yrodent hybrid
(data not shown). Fluorescence in situ hybridization with P1
artificial chromosome clone pDJ487d14 containing part of the
DINB1 gene yielded a single site of hybridization at band 5q13.1,
consistent with the results from the humanyrodent hybrid panel
screen (data not shown). No cross-hybridization to other ho-
mologs was observed. DNA sequencing and PCR analysis
showed that the clone contains only the first two exons of the
DINB1 gene, plus substantial upstream sequence (data not
shown).
Expression of Human DINB1. The predominant DINB1 transcript
observed in human multiple tissue blots is ’5 kb and is present
at low but varying amounts in all tissues examined (Fig. 5A).
Expression of the DINB1 gene is highest in testis, with additional
abundant transcripts of ’3.2 and ’4.4 kb in this tissue. Some of
these transcripts might arise because of the alternative use of the
polyadenylation signal at position 3,276.
To determine whether alternative splicing occurs within the
coding region, the human DINB1 ORF was amplified from
cDNA from a number of human tissues. RT-PCR of HeLa
cDNA consistently yielded a single product of 2,613 bp identical
to the full-length DINB1 ORF reported here (Fig. 5B, lane 2).
This 2,613-bp product was also found in a variety of human
tissues (Fig. 5B, lanes 4–11). In contrast, RT-PCR of human
testis cDNA yielded three products (2,613, 2,344, and 1,484 bp),
consistent with possible alternative splicing within the DINB1
coding region (Fig. 5B, lane 3). These cDNA products were
cloned, and the putative sites of alternative splicing were mapped
(Fig. 1). In the case of human DINB1, both alternate transcripts
are expected to result in frameshift mutations.
RT-PCR of mouse testis cDNA with primers to the 59 and 39
end of the Dinb1 coding region also results in three products
(data not shown). However, the deletions in the mouse Dinb1
alternate transcripts are in frame and are expected to express
distinct protein isoforms that retain a nuclear localization signal.
Intriguingly, one of the mouse Dinb1 alternative-splice products
removes the C-terminal Zn clusters and, hence, may result in a
protein with altered DNA-binding activity. At present it is not
clear why the putative alternative-splice sites in testis are not
conserved between the mouse and human DINB1 genes.
Discussion
The mammalian DinB homologs described here are members of
the UmuCyDinB superfamily of replication bypass DNA poly-
merases (36). The presence of multiple DinB paralogs within
single organisms hints that these genes might have overlapping
functions or that each is required for the bypass of a particular
class of DNA damage. In addition, it seems reasonable to
consider that the activity of these DNA polymerases might be
error-free for some and error-prone for others, depending on the
fidelity of each polymerase and the type of DNA lesion encoun-
tered. For example, the Rad30 branch of the UmuCyDinB
superfamily seems to represent error-free DNA polymerases,
because both the yeast and one of the human homologs (XPV)
have the ability to bypass thymine dimers in template DNA
accurately (12, 14, 15).
Much of our knowledge about the process of mutagenesis in
eukaryotes derives from studies with the yeast S. cerevisiae (1).
Unfortunately, this organism seems to lack a true DinB ortholog,
although it does have related Rad30 and Rev1 proteins. Hence,
it is more difficult to predict the precise catalytic activity of the
mammalian DinB proteins described here. However, based on
the similarity to E. coli DinB, it seems reasonable to suggest that
the mouse and human DinB protein activities participate in an
Fig. 4. Unrooted phylogenetic tree of the UmuCyDinB superfamily. The tree
was generated from a complete multiple alignment of the UmuCyDinB su-
perfamily of proteins (L.A., unpublished work; available on request). The
circles indicate internal nodes with at least 75% bootstrap support. The
subfamilies are indicated as follows: UmuC, green; DinB, red; Rad30, blue; and
Rev1, pink. The apparent human ortholog of Rev1 was not included, because
the sequence is incomplete. Abbreviations are defined in the legend to Fig. 3
and as follows: Dbh Sso, DinB homolog from S. sofataricus; Mpn, Mycoplasma
pneumoniae; Mge, Mycoplasma genitalium; Bs, Bacillus subtilis; SPBc2, bac-
teriophage SPBc2; Mtu, Mycobacterium tuberculosis; and At, Arabidopsis
thaliana.
Fig. 5. Expression of the DINB1 gene in human tissues. (A) Northern blot
analysis of DINB1 expression in human tissues. A human DINB1 cDNA probe
was used to hybridize a multiple-tissue Northern blot (CLONTECH) containing
2 mg of poly(A)1 RNA per lane. A b-actin cDNA probe was used as a control. The
size of the full-length DINB1 transcript and the putative alternative transcripts
are indicated by arrows on the left. (B) RT-PCR analysis of DINB1 expression in
human tissues. RT-PCR was performed on cDNAs from multiple human tissues
by using primers complementary to the 59 and 39 ends of the ORF. Lanes
corresponding to HeLa and testis cDNA are overloaded by comparison with
the other lanes. Samples (20 ml) were analyzed on a 1% agarose gel in TBE.
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error-prone bypass pathway of DNA replication. The human
DINB1 gene might therefore prove to be an oncogene, and its
overexpression may lead to tumorigenesis. Chromosome 5q13
has been identified as a frequent site of deletion and transloca-
tion in human cancers (37). The latter class of rearrangements
is consistent with the hypothesis that DINB1 might be an
oncogene.
We have presented evidence that suggests that the expression
of the mammalian DinB homologs might be regulated posttran-
scriptionally, via messenger stability, alternative polyadenyla-
tion, and alternative splicing within the coding regions. All of
these mechanisms may contribute to regulation of the levels and
activity of the DinB homologs. Such regulation may be critical if
these proteins increase mutagenesis in cells. Finally, we note that
the human DINB1 cDNA is apparently incomplete, because the
largest mRNA observed by Northern analysis is ’5 kb (Fig. 5).
We believe that the missing 1 kb of DINB1 cDNA sequence is in
the 39 UTR. Additional ESTs with similarity to the 39 UTR of
the DINB1 cDNA are present in the National Center for
Biotechnology Information EST database. However, the 39 UTR
contains a repetitive Alu sequence, and it is not possible to
exclude or confirm that these ESTs correspond to the DINB1
gene.
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